Welcome to our dedicated page for TRIO-TECH INTERNATIONAL SEC filings (Ticker: TRT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRIO-TECH INTERNATIONAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRIO-TECH INTERNATIONAL's regulatory disclosures and financial reporting.
Trio-Tech International (TRT) – Form 4 filing dated 07/08/2025 discloses that Chief Financial Officer Anitha Srinivasan was granted 10,000 non-qualified stock options on 07/07/2025. The options carry an exercise price of $5.24 per share and expire on 07/06/2030. Vesting schedule: 2,500 options vest immediately; the remaining 7,500 vest in three equal annual installments thereafter. After the grant, the executive beneficially owns 10,000 derivative securities, all held directly. No shares were bought or sold, and no cash changed hands at the time of grant (price reported as $0).
The filing represents a routine equity-based compensation award designed to align the CFO’s incentives with shareholder value and support retention. The 10,000-share option grant could introduce modest future dilution, but the impact appears limited given the small size relative to typical public-company share counts. No other insider transactions or financial data are included in the document.
Trio-Tech International (NYSE American: TRT) has converted its Chinese testing subsidiary Trio-Tech (Jiangsu) Co. Ltd. into a wholly-owned entity. On 30 June 2025, the company’s intermediate subsidiary, Trio-Tech (SIP) Co., Ltd., purchased the remaining 49% equity interest in Trio-Tech Jiangsu from Suzhou Anchuang Technology Management LLP. Prior to the transaction, Trio-Tech SIP already held 51% of the shares; closing the deal gives Trio-Tech International 100% indirect ownership of the Jiangsu operation. The filing, disclosed under Item 8.01 of an 8-K dated 7 July 2025, contains no purchase price or financial metrics but signals a strategic move to simplify the group structure, gain full operational control, and consolidate all future revenues and earnings from the Jiangsu unit.